marketcap
Facebook
Twitter
Telegram
Report an ErrorFive Prime Therapeutics, Inc. Financial Ratios 2011-2024 | FPRX
Annual Financial Ratios Five Prime Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.3 | -1.2 | -2.7 | -3.9 | -18.1 | 3.7 | -14.7 | -2.9 | - | - |
P/S |
46.7 | 11.3 | 7.7 | 14.8 | 38.8 | 2.4 | 28.5 | 6.0 | - | - |
EV/EBITDA |
-6.3 | -0.8 | -2.4 | -3.5 | -12.2 | 2.7 | -14.8 | -2.7 | - | - |
PEG |
-0.18 | -0.24 | -0.12 | 0.03 | 0.15 | 0.01 | -0.22 | 0.03 | - | - |
P/B |
2.3 | 1.1 | 1.4 | 2.2 | 3.0 | 2.1 | 6.4 | 1.4 | - | - |
P/CF |
-9.5 | -1.5 | -2.9 | -5.0 | -14.4 | 3.2 | 40.3 | -3.2 | - | - |
ROE % |
-31.81 | -91.18 | -52.97 | -56.64 | -16.78 | 57.63 | -43.92 | -49.76 | - | - |
ROA % |
-25.43 | -61.21 | -43.68 | -43.66 | -14.66 | 45.53 | -24.05 | -35.30 | - | - |
ROCE % |
-30.01 | -70.57 | -49.70 | -51.66 | -24.23 | 61.20 | -27.67 | -43.29 | - | - |
DSO |
2.4 | 100.5 | 37.3 | 121.3 | 102.6 | 3.9 | 7.8 | 7.8 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency